[HTML][HTML] Membranous nephropathy

P Ronco, L Beck, H Debiec, FC Fervenza… - Nature reviews Disease …, 2021 - nature.com
Membranous nephropathy (MN) is a glomerular disease that can occur at all ages. In adults,
it is the most frequent cause of nephrotic syndrome. In~ 80% of patients, there is no …

[HTML][HTML] KDIGO 2021 clinical practice guideline for the management of glomerular diseases

BH Rovin, SG Adler, J Barratt, F Bridoux… - Kidney …, 2021 - kidney-international.org
Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …

[HTML][HTML] Rituximab in membranous nephropathy

P Gauckler, JI Shin, F Alberici, V Audard… - Kidney international …, 2021 - Elsevier
Membranous nephropathy is the most common cause of primary nephrotic syndrome among
adults. The identification of phospholipase A2 receptor (PLA2R) as target antigen in a …

[HTML][HTML] The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and …

G Fernández-Juárez, J Rojas-Rivera, AE van De Logt… - Kidney international, 2021 - Elsevier
A cyclical corticosteroid-cyclophosphamide regimen is recommended for patients with
primary membranous nephropathy at high risk of progression. We hypothesized that …

Membranous nephropathy: mechanistic insights and therapeutic perspectives

MR Hua, YL Zhao, JZ Yang, L Zou, YY Zhao… - International …, 2023 - Elsevier
Membranous nephropathy (MN) is one of the most common causes of non-diabetic
nephrotic syndrome in adults. About 80% of cases are renal limited (primary MN) and 20 …

[HTML][HTML] Therapies for membranous nephropathy: a tale from the old and new millennia

F Scolari, F Alberici, F Mescia, E Delbarba… - Frontiers in …, 2022 - frontiersin.org
Primary Membranous Nephropathy (PMN) is the most frequent cause of nephrotic syndrome
in adults. If untreated, PMN can lead to end-stage renal disease; moreover, affected patients …

[HTML][HTML] Recent clinical trials insights into the treatment of primary membranous nephropathy

J Rojas-Rivera, FC Fervenza, A Ortiz - Drugs, 2022 - Springer
Immunosuppressive therapy is mandatory for primary membranous nephropathy with
persistent nephrotic proteinuria or anti-phospholipase A2 receptor antibodies, reduced …

The management of membranous nephropathy—an update

F Caravaca-Fontán… - Nephrology Dialysis …, 2022 - academic.oup.com
In recent decades, several important advances have taken place in the understanding of the
pathogenesis underlying membranous nephropathy (MN) that have sparked renewed …

[HTML][HTML] A review of the current practice of diagnosis and treatment of idiopathic membranous nephropathy in China

L Wu, J Lai, Y Ling, Y Weng, S Zhou, S Wu… - … Medical Journal of …, 2021 - ncbi.nlm.nih.gov
Idiopathic membranous nephropathy (IMN), a common pathological type of nephrotic
syndrome, is one of the main causes of kidney failure. With an increasing prevalence, IMN …

[HTML][HTML] Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis

B Bose, EYM Chung, R Hong, GFM Strippoli… - Journal of …, 2022 - Springer
Background Idiopathic membranous nephropathy is a common cause of nephrotic
syndrome in adults. The Kidney Disease Improving Global Outcomes guidelines …